Comprehensive Analysis of the Hospital And Nursing Home Probiotics Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the hospital and nursing home probiotics market grown in recent years?
The value of the probiotics market in hospitals and nursing homes has enlarged swiftly over the past few years. It’s projected to expand from $1.51 billion in 2024 to $1.69 billion in 2025, experiencing a compound annual growth rate (CAGR) of 11.81%. Factors contributing to the growth witnessed in previous years include heightened comprehension of gut health, an upsurge in gastrointestinal disorder cases, greater acceptance of probiotics in healthcare institutions, and mounting evidence that underlines the health advantages of probiotics.
How is the hospital and nursing home probiotics market size expected to evolve during the forecast period?
In the coming years, swift expansion is anticipated in the hospital and nursing home probiotics market, with expectations to surge to $2.61 billion by 2029 at a compound annual growth rate (CAGR) of 11.44%. The amplified growth during the projection period is linked to the escalating utilization of probiotics, increasing demand for solutions for digestive health, heightened probiotics awareness, an intensified focus on curbing hospital-acquired infections (HAIs), and escalated investments in probiotic-centric medical nutrition. Key trends for the anticipated period encompass breakthroughs in probiotic formulations, enhanced delivery methods targeted towards healthcare surroundings, innovative probiotics for preventing infections, creation of customized probiotics for the elderly and those with compromised immune systems, and the merging of digital solutions.
Get your hospital and nursing home probiotics market report here!
Which key drivers are propelling the hospital and nursing home probiotics market’s growth?
The surge in gastrointestinal disorder cases is projected to fuel the expansion of the hospital and nursing home probiotics market in the future. Gastrointestinal maladies encompass a variety of ailments impacting the digestive system such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and constipation. The escalating case of these disorders is linked to factors like unhealthy eating habits, heightened intake of processed foods, inactive lifestyles, and elevated stress levels. Probiotics used in hospitals and nursing homes aid in managing gastrointestinal problems by reestablishing the beneficial gut flora equilibrium, fostering digestive well-being, and mitigating symptoms like diarrhea, constipation, and bloating. For instance, the IBD Registry, a non-profit organization based in the UK, reported in December 2023 that the number of people diagnosed with Inflammatory Bowel Disease (IBD) exceeded 5,300 by 2023, representing a growth of over 3,000 members from 2022. Hence, the surge in gastrointestinal disorder cases is stimulating the expansion of the hospital and nursing home probiotics market.
What are the market segments in the hospital and nursing home probiotics industry?
The hospital and nursing home probiotics market covered in this report is segmented –
1) By Indication: Antibiotic-Associated Diarrhea, Irritable Bowel Syndrome, Clostridium difficile Infection, Inflammatory Bowel Disease, General Gut Health
2) By Formulation Type: Capsules, Powder, Liquid, Soft Chew, Probiotic Yogurt
3) By Patient Group: Infants, Adults, Elderly, Immunocompromised Patients, Patients With Gastrointestinal Disorders
4) By Distribution Channel: Hospitals, Nursing Homes, Pharmacies, Online Retail, Healthcare Facilities
5) By Application: Gut Health, Immunity, Wellness, Other Applications
Subsegments:
1) By Antibiotic-Associated Diarrhea (AAD): Prevention of AAD, Treatment of AAD
2) By Irritable Bowel Syndrome (IBS): IBS With Diarrhea (IBS-D), IBS With Constipation (IBS-C), Mixed IBS (IBS-M)
3) By Clostridium Difficile Infection (CDI): Prevention of CDI Recurrence, Treatment Of CDI
4) By Inflammatory Bowel Disease (IBD): Crohn’s Disease, Ulcerative Colitis
5) By General Gut Health: Immune System Support, Digestive Health, Gut Microbiome Restoration
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20834&type=smp
Which leading companies are shaping the growth of the hospital and nursing home probiotics market?
Major companies operating in the hospital and nursing home probiotics market are Nestlé Health Science, BASF SE, Procter & Gamble Company, Abbott Laboratories, Lactalis Group, Danone S.A., General Mills Inc., Arla Foods Group, DuPont de Nemours Inc., Kerry Group plc, Koninklijke DSM N.V., Glanbia PLC, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., BioGaia AB, Klaire Labs, SymbioPharm GmbH, Synlogic Inc., Vitakem Nutraceuticals
What emerging trends are influencing the growth of the hospital and nursing home probiotics market?
Major companies operating in the hospital and nursing home probiotics market are focusing on developing innovative products such as probiotic solutions to enhance patient gut health, improve recovery times, and reduce antibiotic-associated side effects. Probiotic solutions refer to products containing live microorganisms that provide health benefits when consumed in adequate amounts, typically by improving the balance of beneficial bacteria in the digestive system. For instance, in October 2024, Probi AB, a Sweden-based biotechnology company specializing in probiotics, launched Metabolic Health by Probi for healthcare settings. metabolic health by probi is a clinically backed probiotic solution designed to support metabolic well-being, cardiovascular health, weight management, and blood pressure regulation by combining two proprietary probiotic strains, Lactiplantibacillus plantarum 299v (LP299V) and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2).
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20834
Which geographic areas are influencing the growth of the hospital and nursing home probiotics market?
North America was the largest region in the hospital and nursing home probiotics market in 2024. The regions covered in the hospital and nursing home probiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Probiotics Global Market Report 2025
https://thebusinessresearchcompany.com/report/probiotics-global-market-report
Probiotics Dietary Supplements Global Market Report 2025
https://thebusinessresearchcompany.com/report/probiotics-dietary-supplements-global-market-report
Probiotics Food And Cosmetics Global Global Market Report 2025
https://thebusinessresearchcompany.com/report/probiotics-food-and-cosmetics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
